Cited by 255Cannabis and Cannabinoid ResearchPain Mechanisms and TreatmentsNerve injury and regeneration

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons

Wotherspoon, G., Fox, A., McIntyre, P., Colley, S., Bevan, S., Winter, J.·2005·Neuroscience

DOI 10.1016/j.neuroscience.2005.06.009

Open this paper in CoChat — free account

Abstract

We have localized cannabinoid receptor 2 protein in rat and mouse somatic sensory nervous system, using an antibody that recognizes mouse cannabinoid receptor 2. Little or no cannabinoid receptor 2 immunoreactivity was found in sections of naive rat or mouse dorsal root ganglia or spinal cord. This was in accord with the lack of detectable cannabinoid receptor 2 mRNA in (dorsal root ganglion) neurons by in situ hybridization experiments described in the literature. However, we could detect cannabinoid receptor 2 immunoreactivity following unilateral nerve damage-either by sciatic nerve section, or by spinal nerve ligation. It was localized to the superficial laminae of the dorsal horn of the spinal cord, ipsilateral to the nerve damage, coincident with the area of termination of damaged afferents which was marked by loss of isolectin B4 binding. This upregulation was not seen in cannabinoid receptor 2 null mice. The cannabinoid receptor 2 protein in spinal cord appeared to be expressed on sensory neuron afferent terminals as it colocalized with two markers of damaged afferents, namely growth associated protein-43 and the neuropeptide galanin. Moreover, it did not colocalize with markers of activated microglial cells (OX-42) or astroglial cells (glial fibrillary acidic protein) in rat spinal cord. In the peripheral nerve, accumulation of cannabinoid receptor 2 immunoreactivity was seen in nerve sections proximal, but not distal, to the ligation site, suggesting transport down the nerve from the cell bodies. Although convincing cannabinoid receptor 2 immunoreactivity was seen in neither uninjured nor injured dorsal root ganglion neuron cell bodies in tissue sections, expression was detectable in isolated, cultured neurons that had received a prior axotomy in vivo. This clear demonstration of CB(2) receptors on sensory neurons suggests an additional cellular target for CB(2) agonist induced analgesia, at least in neuropathic models.

Integrity signals

Registry

Crossref · 10.1016/j.neuroscience.2005.06.009

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat
Ho Kim, S., & Mo Chung, J. (1992) · Pain · doi:10.1016/0304-3959(92)90041-9 · Cited by 3,069
GAP-43: an intrinsic determinant of neuronal development and plasticity
Benowitz, L. I., & Routtenberg, A. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10072-2 · Cited by 1,329
Neuropathic pain and spinal microglia: a big problem from molecules in ‘small’ glia
Tsuda, M., Inoue, K., & Salter, M. W. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.12.002 · Cited by 795
Cannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
Walter, L. M., Franklin, A., Witting, A., Wade, C. B., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01398.2003 · Cited by 674
Modulation of transmitter release via presynaptic cannabinoid receptors
Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671
HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor
Hanus, L. O., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 581
Cannabinoid receptors and their ligands
Pertwee, R. G., & Ross, R. A. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0341 · Cited by 577
The cannabinoid system and immune modulation
Klein, T., Newton, C. A., Larsen, K. A., Lu, L. D., Perkins, I., Nong, L., & Friedman, H. P. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303101 · Cited by 533
CB 2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids
Ibrahim, M. M., Porreca, F., Lai, J., Albrecht, P. J., Rice, F. L., Khodorova, A., Davar, G., Makriyannis, A., Vanderah, T. W., Mata, H. P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409888102 · Cited by 521

Show all 47 references

Sorted by citations

Items 101–200 of 255

Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
Hossain, M. Z., Ando, H., Unno, S., & Kitagawa, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041423 · Cited by 54
Bilateral Changes of Cannabinoid Receptor Type 2 Protein and mRNA in the Dorsal Root Ganglia of a Rat Neuropathic Pain Model
Svíženská, I. H., Brázda, V., Klusáková, I., & Dubový, P. (2013) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155413491269 · Cited by 52
Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis. Role of sensory nerves
DEMBINSKI, A. B., Warzecha, Z., Ceranowicz, P., Warzecha, A. M., Pawlik, W. W., Dembiński, M., Rembiasz, K., Sendur, P., Kuśnierz‐Cabala, B., Tomaszewska, R., et al. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.059 · Cited by 51
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models
Grim, T. W., Ghosh, S., Hsu, K.-L., Cravatt, B. F., Kinsey, S. G., & Lichtman, A. H. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.07.008 · Cited by 50
The Endocannabinoid System: Current Pharmacological Research and Therapeutic Possibilities
Jonsson, K., Holt, S., & Fowler, C. J. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_376.x · Cited by 50
CB2 cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons
Atwood, B. K., Straiker, A. J., & Mackie, K. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.024 · Cited by 50
Mode of action of cannabinoids on nociceptive nerve endings
Kress, M., & Kuner, R. (2009) · Experimental Brain Research · doi:10.1007/s00221-009-1762-0 · Cited by 50
The cannabinoid CB2 receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence
Iyer, V., Slivicki, R. A., Thomaz, A. C., Crystal, J. D., Mackie, K., & Hohmann, A. G. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173544 · Cited by 48
The antinociceptive effect of Δ9-tetrahydrocannabinol in the arthritic rat involves the CB2 cannabinoid receptor
Cox, M. L., Haller, V. L., & Welch, S. P. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.024 · Cited by 48
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model
Greco, R., Mangione, A. S., Sandrini, G., Nappi, G., & Tassorelli, C. (2014) · The Journal of Headache and Pain · doi:10.1186/1129-2377-15-14 · Cited by 46
Normal aging in rats and pathological aging in human Alzheimer’s disease decrease FAAH activity: Modulation by cannabinoid agonists
Pascual, A. C., Martín-Moreno, A. M., Giusto, N. M., CEBALLOS, M. L. D., & Pasquaré, S. J. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.10.011 · Cited by 46
Activation of cannabinoid receptor 2 attenuates mechanical allodynia and neuroinflammatory responses in a chronic post‐ischemic pain model of complex regional pain syndrome type I in rats
Xu, J. J., Tang, Y., Xie, M., Bie, B., Wu, J., Yang, H., Foss, J. F., Yang, B., Rosenquist, R. W., & Naguib, M. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13414 · Cited by 47
Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation
van den Hoogen, N. J., Harding, E. K., Davidson, C. E. D., & Trang, T. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.816747 · Cited by 45
Does Exercise Make Migraines Worse and Tension Type Headaches Better?
Hindiyeh, N. A., Krusz, J. C., & Cowan, R. P. (2013) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0380-5 · Cited by 47
Neuroprotective Effect of JZL184 in MPP+-Treated SH-SY5Y Cells Through CB2 Receptors
Aymerich, M. S., Rojo-Bustamante, E., Molina, C., Celorrio, M., Sánchez-Arias, J. A., & Franco, R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9213-3 · Cited by 45
The cannabinoid CB2 receptor: a good friend in the gut
Izzo, A. A. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00977.x · Cited by 45
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis
Sisay, S., Pryce, G., Jackson, S. J., Tanner, C., Ross, R. A., Michael, G. J., Selwood, D. L., Giovannoni, G., & Baker, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076907 · Cited by 44
Pain Modulation after Oromucosal Cannabinoid Spray (SATIVEX®) in Patients with Multiple Sclerosis: A Study with Quantitative Sensory Testing and Laser-Evoked Potentials
Turri, M., Teatini, F., Donato, F., Zanette, G., Tugnoli, V., Deotto, L., Bonetti, B., & Squintani, G. M. (2018) · Medicines · doi:10.3390/medicines5030059 · Cited by 43
Cannabinoid CB2 receptors are upregulated via bivalent histone modifications and control primary afferent input to the spinal cord in neuropathic pain
Ghosh, K. K., Zhang, G.-F., Chen, H., Chen, S., & Pan, H. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101999 · Cited by 43
Endocannabinoid Receptor Pharmacology
Yao, B. B., & Mackie, K. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_2 · Cited by 44
Functional Characterization and Analgesic Effects of Mixed Cannabinoid Receptor/T-Type Channel Ligands
You, H., Gadotti, V. M., Petrov, R. R., Zamponi, G. W., & Diaz, P. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-89 · Cited by 42
Alternative RNA splicing: contribution to pain and potential therapeutic strategy
Donaldson, L. F., & Beazley‐Long, N. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.06.017 · Cited by 42
New Natural Noncannabinoid Ligands for Cannabinoid Type-2 (CB2) Receptors
Gertsch, J., Raduner, S., & Altmann, K. (2006) · Journal of Receptors and Signal Transduction · doi:10.1080/10799890600942674 · Cited by 42
Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes
Vera, G., López‐Miranda, V., Herradón, E., Martı́n, M. I., & Abalo, R. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.05.008 · Cited by 41
Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy
Nasirinezhad, F., Jergová, S., Pearson, J. P., & Sagen, J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.024 · Cited by 41
Medical marijuana in neurology
Benbadis, S. R., Sanchez‐Ramos, J., Bozorg, A. M., Giarratano, M., Kalidas, K., Katzin, L. W., Robertson, D. S., Vu, T., Smith, A., & Zesiewicz, T. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.985209 · Cited by 40
Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain
Hald, A., Ding, M. L., Egerod, K. L., Hansen, R. B., KONRADSEN, D., JORGENSEN, S., Atalay, B., Nasser, A., Bjerrum, O. J., & Heegaard, A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.04.021 · Cited by 42
Endocannabinoids and Schizophrenia
Desfossés, J., Stip, É., Bentaleb, L. A., & Potvin, S. (2010) · Pharmaceuticals · doi:10.3390/ph3103101 · Cited by 42
CB2 cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: Role of CB2 receptor in pain
Páldy, E., Bereczki, E., Sántha, M., Wenger, T., Borsodi, A. D., Zimmer, A., & Benyhe, S. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.08.005 · Cited by 40
Electroacupuncture potentiates peripheral CB2 receptor-inhibited chronic pain in a mouse model of knee osteoarthritis
Yuan, X., Wang, Q., Su, W., Li, H., Wu, C., Gao, F., Xiang, H.-C., Zhu, H., Lin, L., Hu, X., et al. (2018) · Journal of Pain Research · doi:10.2147/jpr.s171664 · Cited by 41
Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain
Liu, C., & Walker, J. M. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00498.2006 · Cited by 37
Synthetic cannabinoids reduce the inflammatory activity of microglia and subsequently improve neuronal survival in vitro
Young, A. P., & Denovan‐Wright, E. M. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.06.011 · Cited by 37
CB2 receptor deletion on myeloid cells enhanced mechanical allodynia in a mouse model of neuropathic pain
Nent, E., Nozaki, C., Schmöle, A., Otte, D. M., & Zimmer, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-43858-4 · Cited by 37
Histone methyltransferase G9a diminishes expression of cannabinoid CB1 receptors in primary sensory neurons in neuropathic pain
Luo, Y., Zhang, J., Chen, L., Chen, S.-R., Chen, H., Zhang, G.-F., & Pan, H. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011053 · Cited by 37
The endocannabinoid system: A new entry in remote cell death mechanisms
Viscomi, M. T., Oddi, S., Latini, L., Bisicchia, E., Maccarrone, M., & Molinari, M. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.023 · Cited by 37
A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse
Lin, X., Xu, Z., Carey, L. M., Romero, J., Makriyannis, A., Hillard, C. J., Ruggiero, E., Dockum, M., Houk, G., Mackie, K., et al. (2021) · Pain · doi:10.1097/j.pain.0000000000002502 · Cited by 36
Tolerance to WIN55,212-2 is delayed in desensitization-resistant S426A/S430A mice
Nealon, C. M., Henderson, A. N., Hale, D. E., & Morgan, D. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.12.026 · Cited by 34
The neuroprotective role of endocannabinoids against chemical‐induced injury and other adverse effects
Zogopoulos, P., Vasileiou, I., Patsouris, E., & Theocharis, S. E. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2828 · Cited by 34
Molecular Mechanisms Involved in the Antitumor Activity of Cannabinoids on Gliomas: Role for Oxidative Stress
Massi, P., Valenti, M., Solinas, M., & Parolaro, D. (2010) · Cancers · doi:10.3390/cancers2021013 · Cited by 34
Cannabinoids for Neuropathic Pain
Fine, P. G., & Rosenfeld, M. J. (2014) · Current Pain and Headache Reports · doi:10.1007/s11916-014-0451-2 · Cited by 32
A CB2 receptor agonist, A-836339, modulates wide dynamic range neuronal activity in neuropathic rats: Contributions of spinal and peripheral CB2 receptors
McGaraughty, S., Chu, K. L., Dart, M. J., Yao, B. B., & Meyer, M. D. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.015 · Cited by 31
Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model
Cui, J. H., Kim, W. M., Lee, H. G., Kim, Y. O., Kim, C. M., & Yoon, M. H. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2010.12.052 · Cited by 31
Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease
Campillo, N. E., & Paez, J. A. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709788167628 · Cited by 31
Endocannabinoid-serotonin systems interaction in health and disease
Colangeli, R., Teskey, G. C., & Giovanni, G. D. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.003 · Cited by 31
Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic Pain
Henderson, A. N., Crawford, L. C., Sepúlveda, D. E., Hale, D. E., Lesperance, J., & Morgan, D. J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.684115 · Cited by 31
Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of anti-retroviral toxic neuropathy
Carey, L. M., Xu, Z., Rajic, G., Makriyannis, A., Romero, J., Hillard, C. J., Mackie, K., & Hohmann, A. G. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106560 · Cited by 30
Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine
Nagy-Grócz, G., Zádor, F., Dvorácskó, S., Bohár, Z., Benyhe, S., Tömböly, C., Párdutz, Á., & Vécsei, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081617 · Cited by 30
Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain
Sagar, D. R., Jhaveri, M. D., Richardson, D. S., Gray, R., de Lago, E., Fernández‐Ruíz, J., Barrett, D. A., Kendall, D. A., & Chapman, V. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07162.x · Cited by 30
Cellular and behavioral basis of cannabinioid and opioid interactions: Implications for opioid dependence and withdrawal
Mohammadkhani, A., & Borgland, S. L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24770 · Cited by 29
Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis
Fu, W., & Taylor, B. K. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.04.002 · Cited by 29
The endogenous cannabinoid anandamide inhibits transient receptor potential vanilloid type 1 receptor-mediated currents in rat cultured primary sensory neurons
Sántha, P., Jenes, Á., Somogyi, C., & Nagy, I. (2010) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.97.2010.2.1 · Cited by 29
Cannabinoids and neuroinflammation: Therapeutic implications
Leonard, B. E., & Arıcıoğlu, F. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100463 · Cited by 28
Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells
Petrov, R. R., Ferrini, M. E., Jaffar, Z. H., Thompson, C. M., Roberts, K., & Diaz, P. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.099 · Cited by 29
Effects of decompression on neuropathic pain behaviors and skin reinnervation in chronic constriction injury
Tseng, T.-J., Chen, C., Hsieh, Y., & Hsieh, S. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.12.018 · Cited by 28
Medicinal Cannabis and Central Nervous System Disorders
Ortiz, Y. T., McMahon, L. R., & Wilkerson, J. L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.881810 · Cited by 29
Genetic Manipulation of the Endocannabinoid System
Zimmer, A. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_5 · Cited by 26
Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC
Oultram, J. M. J., Pegler, J. L., Bowser, T. A., Ney, L. J., Eamens, A. L., & Grof, C. P. L. (2021) · Biomedicines · doi:10.3390/biomedicines9030234 · Cited by 30
Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain
Ahmed, M. M., Rajpal, S., Sweeney, C., Gerovac, T. A., Allcock, B., McChesney, S. L., Patel, A. U., Tilghman, J. I., Miranpuri, G. S., & Resnick, D. K. (2010) · The Spine Journal · doi:10.1016/j.spinee.2010.08.015 · Cited by 26
Cannabinoids to treat spinal cord injury
Arévalo‐Martín, Á., Molina‐Holgado, E., & García‐Ovejero, D. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.008 · Cited by 27
The role of carbon monoxide on the anti-nociceptive effects and expression of cannabinoid 2 receptors during painful diabetic neuropathy in mice
Castany, S., Carcolé, M., Leánez, S., & Pol, O. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4271-4 · Cited by 26
Neuroinflammation in the Central Nervous System: Exploring the Evolving Influence of Endocannabinoid System
Rathod, S., Agrawal, Y. O., Nakhate, K. T., Meeran, M. F. N., Ojha, S. K., & Goyal, S. N. (2023) · Biomedicines · doi:10.3390/biomedicines11102642 · Cited by 25
Analgesic effects of FAAH inhibitor in the insular cortex of nerve-injured rats
Kim, M. J., Tanioka, M., Um, S. W., Hong, S., & Lee, B. H. (2018) · Molecular Pain · doi:10.1177/1744806918814345 · Cited by 25
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint
Gondim, D. V., de Araújo, J. C. B., Cavalcante, A. L. C., Havt, A., Quetz, J. D. S., Brito, G. A. D. C., Ribeiro, R. D. A., & Vale, M. L. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-130 · Cited by 25
Update on the controversial identity of cells expressing cnr2 gene in the nervous system
Grabon, W., Bodennec, J., Rheims, S., Belmeguenaï, A., & Bezin, L. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13977 · Cited by 24
Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists
Gianella-Borradori, M., Christou, I., Bataille, C. J. R., Cross, R. L., Wynne, G. M., Greaves, D. R., & Russell, A. J. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.11.002 · Cited by 24
Antinociceptive Effects of Racemic AM1241 and Its Chirally Synthesized Enantiomers: Lack of Dependence upon Opioid Receptor Activation
Rahn, E. J., Zvonok, A. M., Makriyannis, A., & Hohmann, A. G. (2010) · The AAPS Journal · doi:10.1208/s12248-009-9170-8 · Cited by 24
Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective
Karst, M., & Wippermann, S. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802691951 · Cited by 24
Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice
Curto-Reyes, V., Boto, T., Hidalgo, A., Menéndez, L., & Baamonde, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.06.057 · Cited by 24
Potential of Endocannabinoids to Control Bladder Pain
Bjorling, D. E., & Wang, Z.-Y. (2018) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2018.00017 · Cited by 24
Behavioral Neurobiology of the Endocannabinoid System
Kendall, D., & Alexander, S. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7 · Cited by 28
Effects of inflammatory pain on CB1 receptor in the midbrain periaqueductal gray
Wilson‐Poe, A. R., Wiese, B. M., Kibaly, C., Lueptow, L. M., Garcia, J. J., Anand, P., Cahill, C. M., & Morón, J. A. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000897 · Cited by 20
Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
Wilkerson, J. L., Bilbrey, J. A., Felix, J. S., Makriyannis, A., & McMahon, L. R. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173192 · Cited by 20
The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief
Wilkerson, J. L., & Milligan, E. D. (2011) · ISRN Anesthesiology · doi:10.5402/2011/593894 · Cited by 20
Therapeutic Applications for Agents that Act at CB1 and CB2 Receptors
Pertwee, R. G., & Thomas, A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-503-9_13 · Cited by 20
The endocannabinoid system: Novel targets for treating cancer induced bone pain
Sun, J., Zhou, Y., Chen, S., Wang, X., Xu, B., Li, D., Tian, Y., & Ye, D. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109504 · Cited by 19
Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians
Narouze, S. (2020) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2020-102114 · Cited by 18
Continuous infusion of the cannabinoid WIN 55,212–2 to the site of a peripheral nerve injury reduces mechanical and cold hypersensitivity
Lever, I. J., Pheby, T., & Rice, A. S. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707210 · Cited by 17
Clinical implications for cannabinoid use in the rheumatic diseases: Potential for help or harm?
Fitzcharles, M., McDougall, J. J., Ste‐Marie, P. A., & Padjen, I. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34522 · Cited by 16
Cannabinoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Abood, M. E., Alexander, S. P. H., Barth, F., Bonner, T. I., Bradshaw, H. B., Cabral, G. A., Casellas, P., Cravatt, B. F., Devane, W. A., Marzo, V. D., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f13/2019.4 · Cited by 15
From Active Ingredients to the Discovery of the Targets: The Cannabinoid Receptors
Mackie, K. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790148 · Cited by 15
Cannabinoid CB1 Receptor Expression and Localization in the Dorsal Horn of Male and Female Rat and Human Spinal Cord
Parnell, J., Martin, N., Dedek, A., Rudyk, C., Landrigan, J., Bellavance, J., VanDerLoo, S., Tsai, E. C., & Hildebrand, M. E. (2023) · Canadian Journal of Pain · doi:10.1080/24740527.2023.2264895 · Cited by 14
Effect of Traditional Chinese Non-Pharmacological Therapies on Knee Osteoarthritis: A Narrative Review of Clinical Application and Mechanism
Liu, Z., Zhang, Y., Liu, J., Wang, Y., Chen, M., Liu, E.-Y., Guo, J.-M., Wang, Y., Weng, Z., Liu, C., et al. (2024) · Orthopedic Research and Reviews · doi:10.2147/orr.s442025 · Cited by 15
The cannabinoid receptors system in horses: Tissue distribution and cellular identification in skin
Kupczyk, P., Rykała, M., Serek, P., Pawlak, A., Słowikowski, B. K., Hołysz, M., Chodaczek, G., Madej, J. P., Ziolkowski, P. P., & Niedźwiedź, А. (2022) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16467 · Cited by 15
No more pain upon G q‐protein‐coupled receptor activation: role of endocannabinoids
Hu, S. S., Ho, Y., & Chiou, L. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12475 · Cited by 16
Retracted
Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenan-induced inflammatory pain
Guenther, K. G., Xu, Z., Romero, J., Hillard, C. J., Mackie, K., & Hohmann, A. G. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109601 · Cited by 13
Genetic Models of the Endocannabinoid System
Monory, K., & Lutz, B. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_5 · Cited by 12
Therapeutic Targeting of Peripheral Cannabinoid Receptors in Inflammatory and Neuropathic Pain States
Spigelman, I. (2009) · Frontiers in neuroscience · doi:10.1201/9781439812105-c5 · Cited by 12
Cannabinoide in der Schmerzmedizin
Karst, M. (2018) · Der Schmerz · doi:10.1007/s00482-018-0299-1 · Cited by 11
Interaction of a Cannabinoid-2 Agonist With Tramadol on Nociceptive Thresholds and Immune Responses in a Rat Model of Incisional Pain
Stachtari, C. C., Thomareis, O., Tsaousi, G. G., Karakoulas, K. A., Chatzimanoli, F. I., Chatzopoulos, S. A., & Vasilakos, D. G. (2014) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000131 · Cited by 10
Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model
Haranishi, Y., Hara, K., & Terada, T. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00250-2 · Cited by 9
The Development of Cannabinoids as Therapeutic Agents in the United States
Murray, C. H., Gannon, B. M., Winsauer, P. J., Cooper, Z. D., & Delatte, M. S. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001121 · Cited by 10
Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord
Milne, M., & Ashton, J. C. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2015.12.060 · Cited by 9
The Endocannabinoid System as a Therapeutic Target in Diabetic Peripheral Neuropathic Pain
Bagher, A. M. (2021) · Journal of Microscopy and Ultrastructure · doi:10.4103/jmau.jmau_97_20 · Cited by 9
Chapter 11 Recent Advances in the Discovery of CB2 Selective Agonists
Han, S., Thatte, J., & Jones, R. M. (2009) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(09)04411-x · Cited by 9
Cannabinoids and Pain Control in the Periphery
McDougall, J. J. (2009) · Wiley eBooks · doi:10.1002/9780470522226.ch13 · Cited by 9
Système cannabinoïde et douleur : vers de nouveaux médicaments ?
Beltramo, M. (2009) · Journal de la Société de Biologie · doi:10.1051/jbio:2009002 · Cited by 8
Novel targets in pain research: The case for CB2 receptors as a biorational pain target
Brownjohn, P. W., & Ashton, J. C. (2009) · Current Anaesthesia and Critical Care · doi:10.1016/j.cacc.2009.07.014 · Cited by 7
Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
Reichenbach, Z. W., DiMattio, K. M., Rajakaruna, S., Ambrose, D., Cornwell, W. D., Tallarida, R. J., Rogers, T. J., Liu‐Chen, L., Tuma, R. F., & Ward, S. J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.803331 · Cited by 7
Cannabinoid CB 2 Receptor Activation Attenuates Fentanyl-Induced Respiratory Depression
Zavala, C. A., Thomaz, A. C., Iyer, V., Mackie, K., & Hohmann, A. G. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0059 · Cited by 7
Contribution of Ion Channel Trafficking to Nociceptor Sensitization
Camprubí-Robles, M., Ferrer-Montiel, A. V., & Planells‐Cases, R. (2010) · The Open Pain Journal · doi:10.2174/1876386301003010108 · Cited by 6

Authors: Wotherspoon, G., Fox, A., McIntyre, P., Colley, S., Bevan, S., & Winter, J.
Affiliations: Novartis (Switzerland) (CH)
Corresponding author: Winter, J.
ORCID: Fox, A.
McIntyre, P.
Bevan, S.
Venue: Neuroscience
Publisher: Elsevier BV
Published: 2005-01
Volume: 135
Issue: 1
Pages: 235-245
ISSN: 0306-4522 (ISSN-L)
DOI: 10.1016/j.neuroscience.2005.06.009
OpenAlex: W2036912145
Cited by: 251
References: 47
Citations by year: 2026: 2 · 2025: 1 · 2024: 3 · 2023: 6 · 2022: 11 · 2021: 10 · 2020: 9 · 2019: 9 · 2018: 10 · 2017: 9 · 2016: 11 · 2015: 6 · 2014: 16 · 2013: 14 · 2012: 11
FWCI: 12.33
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neuroscience (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords: CB2 receptor, peripheral nerve injury, neuropathic pain, sensory neurons, dorsal root ganglia, dorsal horn, sciatic nerve section, spinal nerve ligation, axotomy, galanin, growth-associated protein 43
MeSH terms: Animals, Astrocytes, Ganglia, Spinal, Cricetinae, Immunohistochemistry, Ligation, Male, Mice, Inbred C57BL, Neurons, Afferent, Pain, Peripheral Nervous System Diseases, Spinal Cord, Spinal Nerves, CHO Cells, Rats, Wistar, Microglia, DNA Primers, Mice, Knockout, Receptor, Cannabinoid, CB2, Mice, Rats, Peripheral Nerve Injuries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks